" class="no-js "lang="en-US"> Mario Franco Ruiz, H&T Presspart, on Medical Device Innovation
Sunday, March 26, 2023

Breaking News

Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Celyad Oncology Appoints Georges Rawadi as Its New CEO Companion Spine Closes $60.1 Million Series A Funding Round EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases

March 7 2023

Mario Franco Ruiz, H&T Presspart, on Innovation for Medical Devices

In the video, Mario Franco Ruiz, Sales Manager at H&T Presspart, discusses the company’s latest offerings at the Pharmapack event. He explains that H&T Presspart is showcasing a range of innovative products, including new inhalers and dosing systems, which are designed to enhance the user experience and improve the accuracy and efficiency of drug delivery.

Mario also discusses the importance of not just attracting new customers, but to strengthen the relationship between H&T Presspart and its existing customers.

Overall, Mario emphasizes H&T Presspart’s commitment to innovation and customer satisfaction, and he encourages attendees at Pharmapack to visit the company’s booth to learn more about its latest products and services.

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa

    Diseases

     Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO

    Appointments

     Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round

    Fundraising

     Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis

    News

     Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

    Appointments

     Read more
More On